Cargando…
Survey on the practice of active surveillance for prostate cancer from the Middle East
BACKGROUND: Prostate cancer is the most common cancer among Lebanese men. Management of prostate cancer includes medical, radiological, and surgical intervention. In addition, active surveillance (AS) is proven as a valid option in patients with low-risk prostate cancer. Currently, data from the Mid...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Pacific Prostate Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125368/ https://www.ncbi.nlm.nih.gov/pubmed/32257977 http://dx.doi.org/10.1016/j.prnil.2019.11.001 |
_version_ | 1783515930221871104 |
---|---|
author | El Sebaaly, Ralph Mansour, Mazen Labban, Muhieddine Jaafar, Rola F. Armache, Alexandre Mukherji, Deborah El Hajj, Albert |
author_facet | El Sebaaly, Ralph Mansour, Mazen Labban, Muhieddine Jaafar, Rola F. Armache, Alexandre Mukherji, Deborah El Hajj, Albert |
author_sort | El Sebaaly, Ralph |
collection | PubMed |
description | BACKGROUND: Prostate cancer is the most common cancer among Lebanese men. Management of prostate cancer includes medical, radiological, and surgical intervention. In addition, active surveillance (AS) is proven as a valid option in patients with low-risk prostate cancer. Currently, data from the Middle East about AS are scarce. The aim of this study is to assess the rate of implementation of AS by physicians, determine the selection and follow-up criteria used by physicians, and identify potential barriers to its widespread adoption. METHODS: After receiving ethical approval, a LimeSurvey electronic questionnaire was mailed to 206 eligible urologists, oncologists, and radiation oncologists registered in the order of physicians in Lebanon. The questionnaire included dichotomous, multiple choice questions, and multiple answer questions. The 23 questions tackled sociodemographic information, physician's attitude toward AS, and their current practices. Predictors of AS use were identified using the chi-squared and Fisher's exact test. Then, multivariate logistic regression model for the predictors of AS practice was conducted. RESULTS: The response rate was 25%, and the analysis was run on 52 respondents. Although most of the respondents agreed that AS is a valid modality for low-risk prostate cancer, only 34 (65.4%) of them had patients on active surveillance. The rate of patients on AS was also very low. Urologists, physicians with >15 years of experience, and those who practiced in a university hospital were all predictors of AS usage (p = 0.005; p = 0.002; p = 0.025, respectively). However, physicians with fear of patient noncompliance had the odds of resorting to this modality [odds ratio (OR) = 0.07 (0.01 – 0.76)]. CONCLUSION: The main obstacles to implementing AS were fear of patient noncompliance and lack of national awareness as well as acceptance among the Lebanese uro-oncological body. Efforts to decentralize knowledge and expertize to new health-care practitioners and community hospitals would encourage its implementation. |
format | Online Article Text |
id | pubmed-7125368 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Asian Pacific Prostate Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-71253682020-04-06 Survey on the practice of active surveillance for prostate cancer from the Middle East El Sebaaly, Ralph Mansour, Mazen Labban, Muhieddine Jaafar, Rola F. Armache, Alexandre Mukherji, Deborah El Hajj, Albert Prostate Int Original Article BACKGROUND: Prostate cancer is the most common cancer among Lebanese men. Management of prostate cancer includes medical, radiological, and surgical intervention. In addition, active surveillance (AS) is proven as a valid option in patients with low-risk prostate cancer. Currently, data from the Middle East about AS are scarce. The aim of this study is to assess the rate of implementation of AS by physicians, determine the selection and follow-up criteria used by physicians, and identify potential barriers to its widespread adoption. METHODS: After receiving ethical approval, a LimeSurvey electronic questionnaire was mailed to 206 eligible urologists, oncologists, and radiation oncologists registered in the order of physicians in Lebanon. The questionnaire included dichotomous, multiple choice questions, and multiple answer questions. The 23 questions tackled sociodemographic information, physician's attitude toward AS, and their current practices. Predictors of AS use were identified using the chi-squared and Fisher's exact test. Then, multivariate logistic regression model for the predictors of AS practice was conducted. RESULTS: The response rate was 25%, and the analysis was run on 52 respondents. Although most of the respondents agreed that AS is a valid modality for low-risk prostate cancer, only 34 (65.4%) of them had patients on active surveillance. The rate of patients on AS was also very low. Urologists, physicians with >15 years of experience, and those who practiced in a university hospital were all predictors of AS usage (p = 0.005; p = 0.002; p = 0.025, respectively). However, physicians with fear of patient noncompliance had the odds of resorting to this modality [odds ratio (OR) = 0.07 (0.01 – 0.76)]. CONCLUSION: The main obstacles to implementing AS were fear of patient noncompliance and lack of national awareness as well as acceptance among the Lebanese uro-oncological body. Efforts to decentralize knowledge and expertize to new health-care practitioners and community hospitals would encourage its implementation. Asian Pacific Prostate Society 2020-03 2019-11-30 /pmc/articles/PMC7125368/ /pubmed/32257977 http://dx.doi.org/10.1016/j.prnil.2019.11.001 Text en © 2019 Asian Pacific Prostate Society, Published by Elsevier Korea LLC. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article El Sebaaly, Ralph Mansour, Mazen Labban, Muhieddine Jaafar, Rola F. Armache, Alexandre Mukherji, Deborah El Hajj, Albert Survey on the practice of active surveillance for prostate cancer from the Middle East |
title | Survey on the practice of active surveillance for prostate cancer from the Middle East |
title_full | Survey on the practice of active surveillance for prostate cancer from the Middle East |
title_fullStr | Survey on the practice of active surveillance for prostate cancer from the Middle East |
title_full_unstemmed | Survey on the practice of active surveillance for prostate cancer from the Middle East |
title_short | Survey on the practice of active surveillance for prostate cancer from the Middle East |
title_sort | survey on the practice of active surveillance for prostate cancer from the middle east |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125368/ https://www.ncbi.nlm.nih.gov/pubmed/32257977 http://dx.doi.org/10.1016/j.prnil.2019.11.001 |
work_keys_str_mv | AT elsebaalyralph surveyonthepracticeofactivesurveillanceforprostatecancerfromthemiddleeast AT mansourmazen surveyonthepracticeofactivesurveillanceforprostatecancerfromthemiddleeast AT labbanmuhieddine surveyonthepracticeofactivesurveillanceforprostatecancerfromthemiddleeast AT jaafarrolaf surveyonthepracticeofactivesurveillanceforprostatecancerfromthemiddleeast AT armachealexandre surveyonthepracticeofactivesurveillanceforprostatecancerfromthemiddleeast AT mukherjideborah surveyonthepracticeofactivesurveillanceforprostatecancerfromthemiddleeast AT elhajjalbert surveyonthepracticeofactivesurveillanceforprostatecancerfromthemiddleeast |